Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Arelis

Melbourne start-up developing an at-home urine test with machine learning to screen for endometriosis.

Open the dossier
Opportunities
4
High confidence
070% and above
Counterparts
4startups and investors
  • Distribution 2
  • Co-development 1
  • Investors 1

Distribution2

A channel or customer base to reach together

Use Hormony’s pharmacy kit channel for at-home women’s-health tests

Hormony already sells an at-home hormone kit through the Mannings pharmacy chain, proving a retail route for FemTech kits. Once validated, Arelis' test could follow the same channel and Hormony could broaden its shelf to a second women's-health indication.

20%confidence

Evidence from the records

  • “women's health tests, starting with endometriosis screening from a simple urine sample that can be collected at home”
  • “Kit sold in Hong Kong through the Mannings pharmacy chain.”
If it works
A pre-agreed distribution path for launch, strengthening the seed pitch.
First step
Schedule a founder call with Hormony to learn the pharmacy listing process and terms.

Route screening through IKI’s women’s-health prescribers

IKI equips clinicians who prescribe personalised programmes, notably for menopause; the same prescribers see endometriosis patients. Adding Arelis' screen as an orderable test in IKI would give Arelis a European clinician channel and IKI a diagnostic entry point.

15%confidence

Evidence from the records

  • “notably for menopause”
  • “Professional subscriptions on sale on the website”
  • “Machine learning/AI analysis of a urine sample to build an endometriosis risk profile.”
If it works
A clinician-facing pilot in Spain after validation.
First step
Share a product brief with IKI Health and ask for 3 gynaecologist advisers among its users.

Co-development1

An integration or joint product

Source de-identified clinical data to train and validate the model

Arelis' main gap is clinical data; Cromodata runs a de-identified clinical-data marketplace across dozens of hospitals in five countries. A data partnership could accelerate model development and external validation, and give Cromodata a FemTech data buyer.

20%confidence

Evidence from the records

  • “No clinical data”
  • “Pipeline for de-identifying and standardizing fragmented clinical records”
  • “claimed network of 47 to 84+ healthcare facilities in 5 countries”
If it works
A retrospective validation dataset at lower cost than a de-novo study.
First step
Ask Cromodata whether its network holds gynaecology/endometriosis-coded records and the access price.

Investors1

A fund whose thesis fits

Join StartUp Health’s global pre-seed health portfolio

StartUp Health invests at pre-seed/seed in HealthTech globally and co-led network member Wink Biotherapeutics' pre-seed, offering a warm introduction. Its long-term ‘health moonshot’ format suits an R&D-stage diagnostic.

25%confidence

Evidence from the records

  • “StartUp Health, Dreamward Ventures”
  • “Too early to invest.”
If it works
Pre-seed capital and access to a health-founder community.
First step
Request an intro to StartUp Health from Wink Biotherapeutics' founders.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. Critical Medical DeviceswithLove LifesciencesPeers
    Share drug-delivery device lessons with Love Lifesciences

    Both are US pre-seed drug-delivery device companies founded around a clinical pain point. Exchanging contract manufacturer, regulatory consultant and pharma-partnering contacts saves both time and money.

    30%
  2. Roam TechnologieswithByonyksPeers
    Learn from Byonyks' 2025 FDA class II clearance and US launch set-up

    Byonyks obtained FDA 510(k) clearance for a home-therapy device and is setting up US infrastructure, the exact path Roam must follow. A founder exchange can shorten Roam's regulatory and DME launch planning.

    30%
  3. Lampsy HealthwithLegit.HealthPeers
    Learn from Legit.Health's medical-device certification path

    Legit.Health took an AI medical device through CE marking with an ISO 13485 quality system in Iberia; Lampsy faces the same regulatory steps. A founder exchange shortens the learning curve.

    30%
  4. AlgatekwithAtoz Carbon Cycle PlatformPeers
    Regional microalgae alliance for Malaysia

    Atoz builds nature-based carbon solutions with microalgae in Malaysia but has no public traction; Algatek has installed units at Indonesian SOEs. Sharing technology, MRV methods and possibly licensing Algatek units into Malaysia would give both a bigger regional story.

    25%
  5. Learn from a deployed microalgae business next door

    Algatek has leased microalgae units to Indonesian SOEs and claims IoT-monitored capture; Atoz has a prototype. Licensing or co-selling Algatek's MicroForest in Malaysia could give Atoz an immediate product while it builds its platform.

    25%
  6. Love LifescienceswithCritical Medical DevicesPeers
    Share FDA and QMS learnings between two pre-clearance drug-delivery devices

    Both companies are pre-FDA drug-delivery device makers founded by clinicians. Sharing regulatory consultants, QMS templates and test labs reduces cost for both.

    25%
  7. ZymoChemwithYeast Bay BioPeers
    Davis fermentation network and scale-up playbook

    ZymoChem's CEO trained at UC Davis, where Yeast Bay Bio was founded in 2025. Sharing contract-fermentation contacts, scale-up lessons and DOE/grant experience is low cost and high value for a seed-stage fermentation company.

    25%
  8. LainTechwithBaniqlPeers
    Battery-metals alliance between two atmospheric leaching processes

    Baniql produces battery-grade nickel MHP from Indonesian laterites at low temperature and pressure; Lain Tech treats sulfides containing cobalt and nickel. Together they can present battery offtakers a complementary low-carbon hydrometallurgy portfolio and share know-how on catalysts and scale-up.

    25%
  9. Amass BiosystemswithRegenratePeers
    Borrow Regenrate’s contract-farming model for intercrops

    Regenrate monetises the intercrop period in France with free seed and guaranteed purchase prices — the same farmer-economics problem Amass must solve. Its contract design is a template for Amass' farmer offer.

    20%
  10. BILIXwithPleryon TherapeuticsPeers
    Exchange on polymer-drug CMC and Asian licensing

    Both companies develop polymer-based therapeutics at Series A in Asia. Sharing CMC suppliers, regulatory strategy and licensing contacts reduces cost and time for both.

    20%
  11. Pleryon TherapeuticswithBioSapienPeers
    Compare local-delivery regulatory playbooks

    Both companies build localised, extended-release delivery platforms (BioSapien in oncology implants, Pleryon in ophthalmology). Sharing regulatory and CMC learnings on biodegradable delivery systems reduces costly missteps.

    20%
  12. RegenratewithAmass BiosystemsPeers
    Exchange intercrop-for-bioenergy playbooks

    Amass grows a bioenergy crop alongside corn for biomass; Regenrate grows camelina between crops for biofuel. Both sell farmer income diversification to energy buyers and can share off-take and agronomy learnings across EU/US.

    20%
  13. FluvwithTausiPeers
    Share the gig-provider OS playbook

    Tausi runs an AI-powered operating system for independent beauticians with verified providers and a commission model. Fluv faces the same supply-side problem with pet-sitters; exchanging verification, training and retention practices is useful for both.

    15%
  14. PromptendwithNeurath AIPeers
    AI reliability peer exchange

    Both address trust in AI outputs (Promptend for generated code, Neurath for model predictions) and sell to risk-averse engineering buyers; sharing go-to-market learnings on assurance products is useful.

    15%
  15. PsychoTechwithPromptendPeers
    Moldovan finalist cohort coordination

    Both represent Moldova at the SWC final; pooling travel, investor meetings and Startup Moldova support reduces cost, and PsychoTech could pilot Promptend on its client code.

    15%
  16. ShopperoowithPardon AIPeers
    Benchmark against Pardon AI's profitability agents

    Pardon AI sells AI agents that optimise revenue and margins for retail and food service and has been through Techstars. A founder exchange clarifies positioning and possible specialisation (pricing/assortment vs broader profitability).

    15%
  17. VIEROC AIwithWiseUnitPeers
    Exchange voice-agent and chat-agent learnings with WiseUnit

    WiseUnit sells an AI phone receptionist; VIEROC focuses on chat agents. Comparing pricing, churn and model costs, or white-labelling each other's channel, could help both small teams.

    15%
  18. SchoolACEwithKetzaiPeers
    Learn from Ketzai’s path to 40,000 teachers

    Ketzai solved teacher acquisition for AI lesson planning by aligning with official curricula; SchoolACE can learn its playbook and potentially share content tooling for Spanish-speaking US classrooms.

    15%

Similar profiles

Compatibility score with Arelis

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.